rs7260320

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001256715.2(DNAAF3):​c.666T>C​(p.Ala222Ala) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.336 in 750,756 control chromosomes in the GnomAD database, including 25,479 homozygotes. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.27 ( 5891 hom., cov: 23)
Exomes 𝑓: 0.35 ( 19588 hom. )

Consequence

DNAAF3
NM_001256715.2 splice_region, synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: -0.00300

Publications

10 publications found
Variant links:
Genes affected
DNAAF3 (HGNC:30492): (dynein axonemal assembly factor 3) The protein encoded by this gene is required for the assembly of axonemal inner and outer dynein arms and plays a role in assembling dynein complexes for transport into cilia. Defects in this gene are a cause of primary ciliary dyskinesia type 2 (CILD2). Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]
DNAAF3-AS1 (HGNC:55292): (DNAAF3 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 19-55161416-A-G is Benign according to our data. Variant chr19-55161416-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 257694.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.003 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.505 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001256715.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNAAF3
NM_001256715.2
MANE Select
c.666T>Cp.Ala222Ala
splice_region synonymous
Exon 7 of 12NP_001243644.1
DNAAF3
NM_001256714.1
c.870T>Cp.Ala290Ala
splice_region synonymous
Exon 7 of 12NP_001243643.1
DNAAF3
NM_178837.4
c.807T>Cp.Ala269Ala
splice_region synonymous
Exon 7 of 12NP_849159.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNAAF3
ENST00000524407.7
TSL:1 MANE Select
c.666T>Cp.Ala222Ala
splice_region synonymous
Exon 7 of 12ENSP00000432046.3
DNAAF3
ENST00000455045.5
TSL:1
c.504T>Cp.Ala168Ala
splice_region synonymous
Exon 7 of 12ENSP00000394343.1
DNAAF3
ENST00000528412.5
TSL:1
n.*454T>C
splice_region non_coding_transcript_exon
Exon 7 of 12ENSP00000433826.2

Frequencies

GnomAD3 genomes
AF:
0.270
AC:
34601
AN:
128230
Hom.:
5876
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.511
Gnomad AMI
AF:
0.158
Gnomad AMR
AF:
0.198
Gnomad ASJ
AF:
0.278
Gnomad EAS
AF:
0.117
Gnomad SAS
AF:
0.181
Gnomad FIN
AF:
0.131
Gnomad MID
AF:
0.324
Gnomad NFE
AF:
0.167
Gnomad OTH
AF:
0.271
GnomAD2 exomes
AF:
0.184
AC:
33237
AN:
180944
AF XY:
0.181
show subpopulations
Gnomad AFR exome
AF:
0.514
Gnomad AMR exome
AF:
0.144
Gnomad ASJ exome
AF:
0.292
Gnomad EAS exome
AF:
0.0935
Gnomad FIN exome
AF:
0.105
Gnomad NFE exome
AF:
0.169
Gnomad OTH exome
AF:
0.219
GnomAD4 exome
AF:
0.349
AC:
217470
AN:
622406
Hom.:
19588
Cov.:
23
AF XY:
0.333
AC XY:
107367
AN XY:
322002
show subpopulations
African (AFR)
AF:
0.624
AC:
15375
AN:
24634
American (AMR)
AF:
0.189
AC:
4268
AN:
22556
Ashkenazi Jewish (ASJ)
AF:
0.413
AC:
5899
AN:
14298
East Asian (EAS)
AF:
0.164
AC:
2024
AN:
12350
South Asian (SAS)
AF:
0.187
AC:
11063
AN:
59116
European-Finnish (FIN)
AF:
0.165
AC:
5401
AN:
32658
Middle Eastern (MID)
AF:
0.426
AC:
1368
AN:
3214
European-Non Finnish (NFE)
AF:
0.379
AC:
161709
AN:
426254
Other (OTH)
AF:
0.379
AC:
10363
AN:
27326
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
8612
17223
25835
34446
43058
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5970
11940
17910
23880
29850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.270
AC:
34661
AN:
128350
Hom.:
5891
Cov.:
23
AF XY:
0.265
AC XY:
16285
AN XY:
61544
show subpopulations
African (AFR)
AF:
0.511
AC:
18853
AN:
36860
American (AMR)
AF:
0.198
AC:
2419
AN:
12232
Ashkenazi Jewish (ASJ)
AF:
0.278
AC:
870
AN:
3126
East Asian (EAS)
AF:
0.116
AC:
391
AN:
3380
South Asian (SAS)
AF:
0.180
AC:
598
AN:
3316
European-Finnish (FIN)
AF:
0.131
AC:
959
AN:
7300
Middle Eastern (MID)
AF:
0.316
AC:
79
AN:
250
European-Non Finnish (NFE)
AF:
0.167
AC:
9875
AN:
59284
Other (OTH)
AF:
0.273
AC:
489
AN:
1794
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.523
Heterozygous variant carriers
0
1089
2177
3266
4354
5443
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
316
632
948
1264
1580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.202
Hom.:
2248
Bravo
AF:
0.259
Asia WGS
AF:
0.162
AC:
563
AN:
3472

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:13
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Primary ciliary dyskinesia Benign:3
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jul 15, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

not specified Benign:2
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency

Primary ciliary dyskinesia 2 Benign:2
Sep 21, 2015
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

not provided Benign:2
Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Dilated Cardiomyopathy, Recessive Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Hypertrophic cardiomyopathy Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Familial restrictive cardiomyopathy Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
7.8
DANN
Benign
0.63
PhyloP100
-0.0030
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7260320; hg19: chr19-55672784; COSMIC: COSV61275049; COSMIC: COSV61275049; API